United Therapeutics
UTHR
#1109
Rank
S$28.77 B
Marketcap
S$670.79
Share price
-2.78%
Change (1 day)
73.75%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): S$37.61

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is S$37.54. In 2025 the company made an earnings per share (EPS) of S$38.64 an increase over its 2024 EPS that were of S$33.87.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$37.61-2.69%
2025S$38.6414.1%
2024S$33.8725.59%
2023S$26.9731.54%
2022S$20.5051.18%
2021S$13.56-9.1%
2020S$14.92-581.4%
2019S-$3.10-117.79%
2018S$17.4142.11%
2017S$12.25-40.93%
2016S$20.7413.45%
2015S$18.28104.29%
2014S$8.95100.29%
2013S$4.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.68-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$36.14-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.73-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.50-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$8.41-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.98-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
S-$8.76-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.75-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel